Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868

DNA methylation landscapes: Provocative insights from epigenomics

Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039

The ENCODE (ENCyclopedia Of DNA Elements) Project

(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425

Nitric Oxide Synthases: Properties and Catalytic Mechanism

Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881

Cellular crosstalk in doxorubicin-induced cardiotoxicity: underlying mechanisms and therapeutic strategies

Wei, J., Zhao, Q., Lu, C., Gao, C., Mu, Z., Dong, D., & Sun, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117745 · Cited by 4

CRISPR/Cas9 Screens Implicate RARA and SPNS1 in Doxorubicin Cardiotoxicity

McDermott‐Roe, C., Lv, W., Shao, Y., Hoshino, A., Arany, Z. P., & Musunuru, K. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2026.01.003 · Cited by 4

Pharmaceutical compounds and their toxicity to marine organisms: Emerging contaminants and innovative strategies to reduce pharmaceutical pollution – A review and meta-analysis

Amin, M. F., & Rahman, M. S. (2026) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2026.110519 · Cited by 4

Systems-level integration of machine learning, SHAP explainability, PCA, and network topology reveals multitarget protective actions of tannic acid against doxorubicin toxicity in pentose phosphate pathway

Altunbilek, B., Kizir, D., Karaman, M., Ceylan, H., & Demir, Y. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05236-6 · Cited by 4

CDDO-Me alleviates doxorubicin/lapatinib-induced cardiotoxicity by activating the NRF2/GPX4 axis to inhibit oxidative stress and ferroptosis

Chen, X., Chen, B., Hu, Q., Suo, L., Yin, M., Huang, G., Huang, Z., Yin, Y., & Zhou, W. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.068 · Cited by 4

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma

Hou, Y., Wang, J., & Wang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1284406 · Cited by 4

[Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway].

Wei, J., Yang, Q., Lin, L., Zhu, C., & Wei, J. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.10.05 · Cited by 4

CD146/MCAM links doxorubicin-induced epigenetic dysregulation to the impaired fatty acid transportation in H9c2 cardiomyoblasts

Hasan, A. U., Obara, M., Sato, S., Kondo, Y., & Taira, E. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149370 · Cited by 4

Role of diosmin in preventing doxorubicin-induced cardiac oxidative stress, inflammation, and hypertrophy: A mechanistic approach

Alasmari, A. F., Al-Shehri, M. M., Algarini, N., Alasmari, N. A., Alhazmi, A., Alswayyed, M., Alharbi, M., Alasmari, F. F., & Ali, N. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102103 · Cited by 4

Downregulating miR-432-5p exacerbates adriamycin-induced cardiotoxicity via activating the RTN3 signaling pathway

Geng, W., Yan, S., Sang, D., Tao, J., Zhang, X., Gu, X., & Zhang, X. (2024) · Aging · doi:10.18632/aging.206062 · Cited by 4

Potential Protective Effect of Orlistat: A Formulation of Nanocrystals Targeting Inflammation, Oxidative Stress, and Apoptosis in an Experimental Model of Doxorubicin-Induced Cardiotoxicity

Alsunbul, M., El-Masry, T. A., Zahaby, E. I. E., Gaballa, M. M. S., & El‐Nagar, M. M. F. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111356 · Cited by 4

Double Duty: SGLT2 Inhibitors as Cardioprotective and Anticancer Allies

Piras, L., Zuccanti, M., Tini, G., Volpe, M., Tocci, G., Barbato, E., & Battistoni, A. (2024) · Hearts · doi:10.3390/hearts5040039 · Cited by 4

Diosgenin: A Potential Therapeutic Phytocompound for the Management of Atherosclerosis and Other Physiological Disorders

Rehman, R., Riaz, S., Arooj, M., Khan, S., Tariq, U., & Fatima, M. (2024) · Natural Product Communications · doi:10.1177/1934578x241301228 · Cited by 4

Neoadjuvant chemotherapy and perioperative cardiotoxicity

Tu, Y., Zhou, S., Wang, H., Zhang, P., Liu, C., Zhu, C., & Yang, C. S. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.11.003 · Cited by 4

Shexiang Baoxin Pills alleviate doxorubicin-induced cardiotoxicity via the reactive oxygen species-mediated AKT/Bcl-2 pathway

Wang, S., Chen, M., Qian, Y., Chen, X., & Xu, W. (2024) · Medicine · doi:10.1097/md.0000000000040287 · Cited by 4

Novel nanographene oxide conjugates as stimuli-responsive theranostic tool for cancer

Araújo-Silva, H., Martins, B., Cerqueira, F., Gonçalves, H., Machado, R., Gomes, A. C., & Lúcio, M. (2025) · Materials Today Chemistry · doi:10.1016/j.mtchem.2025.102552 · Cited by 4

Trim65 mitigates doxorubicin-induced myocardial injury by reducing ferroptosis

Ma, X., Chen, W., Hu, Z., Xie, L., Li, Z., Liu, H., Li, Z., Jiang, Z., Huang, J., Jiang, C., et al. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114613 · Cited by 4

Circular RNAs as regulatory mediators and therapeutic targets in doxorubicin-induced cardiotoxicity

Fang, S., Ainsworth, T., & Zhang, P. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103106 · Cited by 4

Glycitein Mitigates Doxorubicin‐Induced Cardiotoxicity by Mitigating Apoptosis and Inflammatory Responses in Albino Rats

Jingya, Z., & Peng, L. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70489 · Cited by 4

Genetic basis of anthracyclines cardiotoxicity: Literature review

Sinitsky, M. Y., Цепокина, А. В., Khutornaya, M. V., Ponasenko, A. V., & Sumin, A. N. (2021) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2021-6.4.3 · Cited by 4

Cardioprotective Effect of Centaurea castriferrei Borbás & Waisb Extract against Doxorubicin-Induced Cardiotoxicity in H9c2 Cells

Humeniuk, E., Adamczuk, G., Kubik, J., Adamczuk, K., Józefczyk, A., & Korga-Plewko, A. (2023) · Molecules · doi:10.3390/molecules28010420 · Cited by 4

Doxorubicin-induced oxidative stress injury: The protective effect of kumiss on cardiotoxicity

Yilmaz, S., Kaya, E., Yonar, H., & Mendĭl, A. S. (2022) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.27822 · Cited by 4

Biodegradable porous polymeric drug as a drug delivery system: alleviation of doxorubicin-induced cardiotoxicity via passive targeted release

Jiao, Q., Liu, B., Xu, X., Huang, T., Cao, B., Wang, L., Wang, Q., Ailing, D., Li, J., Zhou, B., et al. (2023) · RSC Advances · doi:10.1039/d2ra07410a · Cited by 4

Propolis flavonoids liposome ameliorate doxorubicin-induced cardiotoxicity in rats

(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.04.022 · Cited by 4

Outcome of serial cardiac evaluations during doxorubicin-based chemotherapy in small- to medium-sized dogs with multicentric lymphoma

Tang, Y. S., & Wang, S. L. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106134 · Cited by 4

Cardioprotective Mechanism and Active Compounds of Folium Ginkgo on Adriamycin-Induced Cardiotoxicity: A Network Pharmacology Study

Sun, X., Zhu, Y., Li, F., Li, M., & Wan, G. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/4338260 · Cited by 4

Sustained doxorubicin delivery system to breast tumor cancer cell based on a novel cationic molecularly imprinted polymer

Farhad-Gholami, N., Hashemi‐Moghaddam, H., Shaabanzadeh, M., Zavareh, S., & Madanchi, H. (2021) · International Journal of Polymeric Materials · doi:10.1080/00914037.2021.2008392 · Cited by 4

Evaluation of the Effect of Virgin Rice Bran Oil (VRBO) on Doxorubicininduced Cardiotoxicity in Wistar Rats

Prema, S., Verma, R., Nagarwal, A., Bharkatiya, M., Baghel, M., Kishore, L., Wal, P., & Gasmi, A. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x327970250108045235 · Cited by 3

Targeting cardiotoxicity: the potential of Annona squamosa L. in doxorubicin therapy

Lele, K. A., Patil, P. P., Kakade, S. V., Maledavar, N. R., Ranade, S. D., Alegaon, S. G., Biradar, P. R., & Khatib, N. A. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00333-5 · Cited by 3

Identification of novel small molecule inhibitors of ETS transcription factors

Abdalla, S., Forghany, Z., Ma, J., Hollander, J. G., Nachane, R., Szuhai, K., Hogendoorn, P. C. W., ten Dijke, P., Shah, D., & Baker, D. A. (2025) · FEBS Letters · doi:10.1002/1873-3468.70040 · Cited by 3

D-limonene complexed with hydroxypropyl-β-cyclodextrin prevents impaired cardiac excitation-contraction coupling by reducing oxidative stress and cardiac apoptosis in an animal model of cardiotoxicity induced by doxorubicin

Durço, A. O., Souza, D. S., Conceição, M. R. D. L., Beserra, S. S., Teixeira‐Fonseca, J. L., Loch, L., Silva, M. A., de Oliveira, A. P., Araújo, A. A. D. S., de Vasconcelos, C. M. L., et al. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111580 · Cited by 3

Sublethal Doxorubicin Promotes Extracellular Vesicle Biogenesis in A375 Melanoma Cells: Implications for Vesicle-Loaded TGF-β-Mediated Cancer Progression and Cardiovascular Pathophysiology

Fernández-Fonseca, L. F., Novoa-Herrán, S. S., Umaña‐Pérez, A., & Gómez, L. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178524 · Cited by 3

A Brief Review on Pharmacological Efficacy of Chelidonic Acid

Harish, K. S., Sivasankaran, S. M., Manoharan, S., & Sakthisankaran, S. M. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i9.7352 · Cited by 3

Unveiling a Doxorubicin‐Cytochrome P450 Electron Transfer Pathway for Synergistic Multimodal Tumor Therapy

Yin, W., Liu, Z., An, S., Song, T., Wang, Y., & Jiang, X. (2025) · Small Methods · doi:10.1002/smtd.202501358 · Cited by 3

A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy‐Induced Cardiotoxicity

Yoo, J., Mainkar, G., Ghiringhelli, M., dos Santos, B. G., Żak, M. M., Kaur, K., Kurian, A. A., Adjmi, M., Sharon, S., Markopoulou, E., et al. (2026) · Advanced Science · doi:10.1002/advs.202510543 · Cited by 3

Protective effect of Baicalin against doxorubicin-induced cytotoxic and electrophysiological damage in human iPSC-cardiomyocytes

Ulivieri, A., Lavra, L., Magi, F., Morgante, A., Martinelli, E., & Salehi, L. B. (2026) · Scientific Reports · doi:10.1038/s41598-026-38838-4 · Cited by 3

A simplified co-culture reveals altered cardiotoxic responses to doxorubicin in hPSC-derived cardiomyocytes in the presence of endothelial cells

Brescia, M., Gallant, J., Chatrian, A., Keselman, P., Paulsson, E. S., Mol, M. P. H., Sjögren, R., Raymond, K., Orlova, V. V., Barnes, K., et al. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102816 · Cited by 3

pH-Responsive Chitosan–Agarose/ZnO Hybrid Nanocomposites for Controlled Doxorubicin Release and Targeted Brain Cancer Therapy

Pourmadadi, M., biglari, P., Shabestari, S. M., Yaghoobi, R., Ajalli, N., Hashemipour, M., Bahramian, M., Ghaderi, I., Mehrabi, M. G., & Sharifianjazi, F. (2026) · Journal of Polymers and the Environment · doi:10.1007/s10924-026-03805-7 · Cited by 3

A Simple Clinical Risk Score to Improve Prediction of Anthracycline-Induced Cardiotoxicity

Cardinale, D. M., Cosentino, N., Morocutti, C., Quaggiotti, L., Marenzi, V., García, J. S., López‐Fernández, T., Piacentini, L., Bonomi, A., & Marenzi, G. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2026.06.005 · Cited by 3

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer

Wen, H., Poutiainen, P., Batnasan, E., Latonen, L., Lehto, V., & Xu, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102507 · Cited by 3

Phytohemagglutinin from Phaseolus vulgaris enhances the lung cancer cell chemotherapy sensitivity by changing cell membrane permeability

Wang, P., Min, S., Chen, C., Hu, J., Wei, D., & Wang, X. (2024) · Journal of Natural Medicines · doi:10.1007/s11418-023-01772-0 · Cited by 3

Doxorubicin-based ENO1 targeted drug delivery strategy enhances therapeutic efficacy against colorectal cancer

Liu, J., Hu, X., Yu, G., Wang, Q., Gu, L., Shen, J., Zhao, Q., Sun, H., Wang, S., Guo, Z., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116220 · Cited by 3

Using Poly(N‐isopropylacrylamide) and Poly(ethyleneglycol) Grafted Polycarbodiimides as Unique Nanocarriers for Hydrophobic Form of the Doxorubicin ( DOX )

Siriwardane, D. A., Karmegam, V., Kulikov, O. V., & Novak, B. M. (2024) · Journal of Polymer Science · doi:10.1002/pol.20230905 · Cited by 3

The protective effect of Ghrelin peptide on doxorubicin hydrochloride induced heart failure in rats

Peng, Y., Zhang, P., Zou, P., Zhou, Y., & Shao, L. (2024) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-02994-3 · Cited by 3

Omega 3 fish oil-based lipid nanocapsules augment the therapeutic effects of vitamin D3 in a rat model of doxorubicin-induced cardiotoxicity

Mottelib, L. M. M. A. A. E., Shehata, E. M. M., Ibrahim, H. F., Aziz, M. A., Basta, M., Assem, S., Ali, M. A., & Mady, B. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106536 · Cited by 3

Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines

Pereira, J. C., de Sousa, R. W. R., Conceição, M. L. P., do Nascimento, M. L. L. B., de Almeida, A. T. A., dos Reis, A. C., Cavalcante, M. L. D. S., Oliveira, C. D. R., Martins, I. R. R., Torres‐Leal, F. L., et al. (2025) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2448663 · Cited by 3

Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation

Xu, A.-L., Shen, Z., Wang, S., Luan, H., Xu, Y., Kang, Z.-C., Liao, Z.-Q., Liu, J., Duan, X.-L., Bian, W., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1496380 · Cited by 3

The role of HDAC2 inhibition in cardioprotection against doxorubicin-induced myocardial injury

Liu, J., Fu, W., Wang, X. L., Liang, Z., & Meng, F. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1557119 · Cited by 3

QbD assisted development of hyaluronic acid and TPGS incorporated DOX liposome(s): in vitro assessment of cytotoxicity, uptake, ROS, and NF-κB potential on MDA-MB-231 cells

Kumari, L., Singh, R., Patel, P., Singh, A., Singh, D., Sharma, N., Gupta, G. D., & Kurmi, B. D. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04053-7 · Cited by 3

Enhanced anticancer effect of cholesteryl doxorubicin liposome-extracellular vesicle hybrid

Choi, J., Park, J.-W., & Doh, K. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106981 · Cited by 3

Mitochondrial DNA depletion syndrome and its cardiac complication

Bao, S., Ye, J., Zhou, J., Chen, Z., Xu, Y., & Sun, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1582219 · Cited by 3

Exploration of multifunctional doxorubicin-loaded polydopamine-coated supermagnetic Fe3O4 and au@Fe3O4 nanocomposites for efficient treatment of MDA-MB-453 breast cancer cells

Matar, G. H., & Andaç, M. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.115315 · Cited by 3

1,25(OH)2D3 ameliorates doxorubicin‑induced cardiomyopathy by inhibiting the NLRP3 inflammasome and oxidative stress

Gu, X., Zhao, L., Ye, J., Chen, L., Sui, C., Li, B., Wang, X., Zhang, J., & Du, Y. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12112 · Cited by 3

Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity

Law, D., Magrini, M. A., Siedlik, J. A., Eckerson, J. M., Drescher, K. M., & Bredahl, E. C. (2023) · Nutrients · doi:10.3390/nu15184048 · Cited by 3

Novos Biomarcadores Cardiovasculares em Pacientes com Câncer de Mama Submetidas a Quimioterapia à Base de Doxorrubicina

Pestana, R. M. C., Silvino, J. P. D. P., de Oliveira, A. N., Soares, C. E., Sabino, A. D. P., Simões, R. S., & Gomes, K. B. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230167 · Cited by 3

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Chu, J., Tung, L., Atallah, I., Wei, C., Cobleigh, M., Rao, R. D., Feinstein, S. B., Usha, L., Banach, K., Reiser, J., et al. (2024) · Cardio-Oncology · doi:10.1186/s40959-023-00191-0 · Cited by 3

CYTOTOXICITY SCREENING AND ANTIOXIDANT CAPACITY ASSESSMENT OF THE INNER PERIANTH SEGMENTS OF 14 RUMEX SPECIES GROWN IN TÜRKİYE

Özenver, N., ERKMEN, Y., Boyali, F., & Demirezer, L. Ö. (2024) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1391998 · Cited by 3

Chromolaena odorata L. Leaf Extract Elevates Cytotoxicity of Doxorubicin on 4T1 Breast Cancer Cells

Putri, A. P., Rahmawati, D. R., Rahman, F. A., Meiyanto, E., & Ikawati, M. (2024) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev14iss3pp160-170 · Cited by 3

Africa leaf (Vernonia amygdalina Delille.) DCM extract synergistically supports growth suppression effect of doxorubicin on MCF7 and MCF7/HER2 with different effects on cell cycle progression and apoptosis evidence

Hapsari, N. P., Rahmawati, D. R., Nugraheni, N., Hanifa, M., Satria, D., Hasibuan, P. A. Z., & Meiyanto, E. (2024) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2024.180163 · Cited by 3

Combining Water‐Soluble Porphyrin and Phthalocyanine Photosensitizers With Doxorubicin Improves the Efficacy of Chemo‐Photodynamic Therapy Against DMBA‐Induced Breast Carcinoma

Mokhtar, A., Mohamed, T. A., Eigza, A. O., & El‐Khouly, M. E. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402782 · Cited by 3

The citrus flavonoid nobiletin prevents the development of doxorubicin-induced heart failure by inhibiting apoptosis

Sunagawa, Y., Iwashimizu, S., Ono, M., Mochizuki, S., Iwashita, K., Sato, R., Shimizu, S., Funamoto, M., Shimizu, K., Hamabe‐Horiike, T., et al. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.03.011 · Cited by 3

Safety of ifosfamide during pregnancy: A comprehensive analysis

Devant, C., Pietri, T., Auffret, M., Lagarce, L., Barrois, M., Tréluyer, J., Tsatsaris, V., & Chouchana, L. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114003 · Cited by 3

Canine mammary carcinoma: current therapeutic targets and future perspectives – a review

Nordin, M. L., Azemi, A. K., Ismail, N., Nordin, A. H., Nabgan, W., Noralidin, N. A., Shaari, R., Rajdi, N. Z. I. M., Reduan, M. F. H., Siti, H. N., et al. (2023) · Annals of Animal Science · doi:10.2478/aoas-2022-0085 · Cited by 3

Fasting: A Complex, Double-Edged Blade in the Battle Against Doxorubicin-Induced Cardiotoxicity

Meng, Y., Sun, J., Zhang, G., Yu, T., & Piao, H. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09925-7 · Cited by 3

Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials

Zhao, M., Zhang, X., Zhou, D., & Song, J. (2025) · Open Access Journal of Clinical Trials · doi:10.2147/oajct.s501501 · Cited by 3

Empagliflozin alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress via modulation of the JNK/Nrf2 signaling pathwayPreprint

Peng, G., Ni, L., Guo, Z., Huang, L., Ma, W., Zheng, F., Zhang, Y., Fengfei, 高. G., Wang, Z., & Cai, W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.05.697595 · Cited by 3

Esculetin Attenuates Doxorubicin-Induced Kidney Damage By Reducing Heat Shock Proteins Expression Levels

Yeşilkent, E. N., Kizir, D., Karağaç, M. S., Öztürk, N., Karadaş, H., Tosun, H., Karaman, M., Ceylan, H., & Demir, Y. (2024) · Journal of Laboratory Animal Science and Practices · doi:10.62425/jlasp.1428071 · Cited by 2

Dehydroevodiamine Alleviates Doxorubicin‐Induced Cardiomyocyte Injury by Regulating Neuregulin‐1/ErbB Signaling

Jie, S., Guo, W., & Lebo, S. (2024) · Cardiovascular Therapeutics · doi:10.1155/cdr/5538740 · Cited by 2

MICRORNA-146B TARGETS HIF-1Α AND ATTENUATES CARDIOMYOCYTE APOPTOSIS AND FIBROSIS IN DOXORUBICIN-INDUCED HEART FAILURE

Wang, M., Lu, R., Peng, L., Xu, L., He, S., Guo, T., Lu, M., Luo, Y., & Cui, T.-T. (2025) · Shock · doi:10.1097/shk.0000000000002546 · Cited by 2

The impact of CBR3 (rs1056892) and ABCC1 (rs45511401) genetic polymorphisms on doxorubicin-induced cardiotoxicity and the potential role of brain natriuretic peptide as an early cardiac biomarker in breast cancer patients

El-Shorbagy, E. A., El‐Bassiouny, N. A., Kassem, A. B., Salahuddin, A., Kamel, M. M., Bastawisy, A. E., & Abuelsoud, N. N. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2490736 · Cited by 2

Matrix metalloproteinase inhibition protects against junctophilin‐2 proteolysis during doxorubicin‐induced cardiotoxicity

Bassiouni, W., Chan, B. Y. H., Roczkowsky, A., Kranrod, J. W., Mahmud, Z., Primeau, J. O., Cho, W. J., Young, H. S., Seubert, J. M., & Schulz, R. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70047 · Cited by 3

Forskolin attenuates doxorubicin-induced cardiotoxicity by activating SIRT1/FOXO1/PINK1/Parkin-mediated mitophagy

Momen, Y. S., Kandeil, M. A., & Mahmoud, M. O. (2025) · Scientific African · doi:10.1016/j.sciaf.2025.e02765 · Cited by 2

Herbo‐Mineral Medicine, Cardiogrit Gold, Exhibits Protective Effects in Caenorhabditis elegans Model of Doxorubicin‐Induced Cardiotoxicity

Balkrishna, A., Bhatti, S., Tomer, M., Verma, S., Dev, R., & Varshney, A. (2025) · Journal of Toxicology · doi:10.1155/jt/4609428 · Cited by 2

Is the use of anthracyclines implicated in myocardial injury? Investigating the cardio modulatory effects of naringenin and apocynin in doxorubicin-induced cardiotoxicity in rats

Beshel, J. A., Ukweni, S. U., Okon, I. A., & Owu, D. U. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102116 · Cited by 2

Cardiovascular Disease Meets Cancer: Exploring the Epidemiology in China and Homotherapy Targeting Intersectional Mechanisms

Xiang, S., Shan, Y., Shi-hong, X., Wang, J., Luo, M., Zhou, J., & Chen, Q. (2025) · Advanced Science · doi:10.1002/advs.202501820 · Cited by 2

DFT and MD investigations of doxorubicin-Pertuzumab delivery via PLGA nanocarriers: Thermodynamic stability and optical properties

Alanazi, M., & Alharby, T. N. (2025) · Case Studies in Thermal Engineering · doi:10.1016/j.csite.2025.106986 · Cited by 2

Mechanistic Insights into the Anticancer Action of Novel 2-Hydroxy-1,4-naphthoquinone Thiol Derivatives

Santos, T. B., Canuto, A. D. S. C. L., Meira, J. F. B. V. D. C., Santos-Diniz, A. C., Ribeiro, R. M. D. A. C., Paschoal, C. R. S., Rabelo, V. W., Abreu, P. A., Ferreira, V. F., da Rocha, D. R., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c06730 · Cited by 2

Fabrication and Computational Study of pH-Responsive Chitosan/Poly(HEMA-co-2-HMBA) Microparticles for Controlled, Site-Specific Doxorubicin Delivery

Reddy, N. S., Chitumalla, R. K., Choi, J., Jang, J., Seo, H. I., & Chung, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110460 · Cited by 2

Synergistic benefits of melatonin and therapeutic exercise as a unified strategy for managing stroke and doxorubicin-induced cardiotoxicity

Park, S., Khan, Z. A., Hong, Y., Shin, J.-H., Lkhagvasuren, T., Lee, S., & Hong, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1567263 · Cited by 2

Non-canonical role of natural quinones in mitochondrial nucleoid organization for maintaining respiration and protecting cardiac function

Pal, S., Ishihara, T., Setoyama, D., Chen, C.-L., Onoue, K., Yonemura, S., Ogasawara, E., & Ishihara, N. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf062 · Cited by 2

ENHANCED COMBINED EFFECTS OF GARCINIA COWA BARK EXTRACT AND DOXORUBICIN ON CELL CYCLE REGULATION AND P53 EXPRESSION IN T47D BREAST CANCER CELLS

Ifora, I., Dachriyanus, D., SUSANTI, M., & Wahyuni, F. S. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i6.54533 · Cited by 2

A novel radiosensitizer α-sulfoquinovosyl-acylpropanediol (SQAP) inhibits DNA repair pathways and sensitize cells to cancer chemotherapeutic agents

Maëda, J., Sunada, S., Fukuhara, T., & Kato, T. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-25524-0 · Cited by 2

RSL3 Mitigates Doxorubicin Resistance in Breast Cancer via Targeted Disruption of Glycolytic Flux

Li, M., Wang, X., Hong, J., Guan, X., Chen, Y., zhou, H., Wang, X., Liang, B., Gao, X., Wu, Y., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202503259r · Cited by 2

Curcumin as a modulator of IL-18: A promising therapeutic approach for inflammatory diseases

Kavyani, M., Ghoflchi, S., Disfani, S. M., Jalili‐Nik, M., Sadeghi, A., Karav, S., Kesharwani, P., Hosseini, H., & Sahebkar, A. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.108211 · Cited by 2

The Optimal Amount of PAMAM G3 Dendrimer in Polyurethane Matrices Makes Them a Promising Tool for Controlled Drug Release

Zaręba, M., Twardowska, M., Błoniarz, P., Lechowicz, J. B., Czechowicz, J., Łysik, D., Rzepna, M., & Uram, Ł. S. (2026) · Polymers · doi:10.3390/polym18010135 · Cited by 2

Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies

Lin, X., Wu, Z., Liu, Y., & Liao, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1668623 · Cited by 2

GSDMD inhibitor GI-Y1 alleviates doxorubicin-induced cardiotoxicity via the inhibition of mitochondrial dysfunction

Zhang, Y., Zheng, R., Xie, M., Chen, Y., Xia, B., Yang, Z., Li, Z., Li, Y., Luo, L., Huang, W., et al. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117713 · Cited by 2

Anti-PD-1 immune checkpoint inhibitor-induced cardiotoxicity is associated with dysfunctional metabolism, muscle wasting and autophagy

Tichy, L., & Parry, T. L. (2026) · Scientific Reports · doi:10.1038/s41598-025-34379-4 · Cited by 2

Multi-omics reveals hepatotoxic mechanisms and key toxic components of Polygoni Multiflori Radix and its processed products

Wu, Q., Chen, Z., Hou, Z., Liu, Z., Sun, R., & Liu, S. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157908 · Cited by 2

Hydrogen Nanobubbles Inhibit Oxidative Stress and Myocardial Fibrosis to Reverse Chemotherapy-Induced Myocardial Injury

Xie, T., Li, N., Hu, X., Liu, H., Liu, Y., Zhang, Y., Wang, C., & Liu, L. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c22351 · Cited by 2

Engeletin alleviates doxorubicin-induced cardiotoxicity via the AMPK pathway in mice

Chen, X., Zhong, X., Luo, D., Huang, Q., Tang, P., Ye, L., Lei, Y., & Huang, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1741741 · Cited by 2

Doxorubicin-Induced Cardiotoxicity: Molecular Mechanisms to Novel Therapeutic Frontiers of Recent Preclinical Discoveries

Dubey, N., Singh, S., Panchbhai, P., Chaturvedi, G., Goyal, A., Singh, N., Bhatia, J., Yadav, R. K., Arava, S. K., Kumar, A., et al. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-02054-8 · Cited by 2

Polyhedral Oligomeric Silsesquioxane Based Material for Tumor Heterogeneity MR Visualization and Precise Treatment

Geng, X., Zhuang, Z., Zhang, J., Zhao, X., Lyu, H., Fu, Z., Liu, X., Qian, T., Li, Z., Chen, T., et al. (2026) · SusMat · doi:10.1002/sus2.70061 · Cited by 2

Self-assembly of glycyrrhizic acid and aconitine alleviates heart failure by inhibiting autophagy and inducing reprogramming of energy metabolism

Liu, Y., Pu, Z., Chen, X., Peng, Y., Peng, C., & Li, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158094 · Cited by 2

Salubrinal-activated integrated stress response protects against doxorubicin-induced cardiotoxicity via activating transcription factor 4-mediated antioxidant defense and glutathione homeostasis

Wang, S., Chou, H.-Y., Liu, P.-H., Su, H.-H., Hung, G., Chou, C., Tseng, L., Shen, Y., Yen, J., Huang, S., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.281 · Cited by 2

Chondroitin sulfate-functionalized GSH-responsive lipid-nanoparticle inhibits melanoma metastasis through suppressing STAT3 activation

Yao, Y., Zhang, M., Xu, S., Wu, G., Meng, X., Li, J., & Yu, H. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126989 · Cited by 2

Doxorubicin-Induced Cardiotoxicity in Breast Cancer: Mechanistic Pathways, Pharmacogenomic Modifiers, and Translational Strategies

Kuok, C.-T., Lee, H.-W., Huang, C., Cheng, Y.-C., Lin, S., & Guo, J.-W. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10132-9 · Cited by 2

Hydrophobic NADES-Derived Pumpkin Carotenoid Extract Attenuates Oxidative Stress and Mitochondrial Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity

Bosanac, M., Andrejić-Višnjić, B., Popović, A., Ljubković, M., Martić, N., Miljković, D., Stupar, A., & Cvetković, B. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060662 · Cited by 2

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation

de Sá, L. A., de Lima, L. N., Andrade, D. C., Cândido-Santos, J. H., Melo, B. R., Santana-Souza, C. A., Rodrigues, A. L. P., & Lauton‐Santos, S. (2026) · Current topics in membranes · doi:10.1016/bs.ctm.2026.04.003 · Cited by 2

Ferroptosis regulation in doxorubicin-induced cardiotoxicity: multi-mechanism interventions and translational strategies

Chen, X., Lu, Y., Wang, Y., Kou, Y., Gu, Y., & Lin, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1852342 · Cited by 2

Doxorubicin-induced phosphorylation of lamin A/C enhances DNMT1 and activates cardiomyocyte death via suppressing GATA-4 and Bcl-xL in rat heart

Tiwari, V., Salgar, S., Jorvekar, S. B., Kumbhar, B. M., Arava, S. K., Borkar, R. M., & Banerjee, S. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167692 · Cited by 5

Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity

Ferreira, A., Cunha‐Oliveira, T., Simões, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K. K. S., Wallace, K. B., & Oliveira, P. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.08.011 · Cited by 78

Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature

Chen, Y., Huang, T., Shi, W., Fang, J., Deng, H., & Cui, G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.150 · Cited by 31

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity

Arrigoni, R., Jirillo, E., & Caiati, C. (2025) · Toxics · doi:10.3390/toxics13040277 · Cited by 37

Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.

Saleh, M. F., El‐Sayad, M. E., & Goda, A. E. (2021) · PubMed · doi:10.26355/eurrev_202111_27100 · Cited by 6